These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29349483)

  • 21. Pathological complete response in invasive breast cancer treated by skin sparing mastectomy and immediate reconstruction following neoadjuvant chemotherapy and radiation therapy: Comparison between immunohistochemical subtypes.
    Barrou J; Bannier M; Cohen M; Lambaudie E; Gonçalves A; Bertrand P; Buttarelli M; Opinel P; Sterkers N; Tallet A; Zinzindohoué C; Houvenaeghel G
    Breast; 2017 Apr; 32():37-43. PubMed ID: 28033508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
    Ryu JM; Park S; Paik HJ; Nam SJ; Kim SW; Lee SK; Yu J; Bae SY; Kim I; Bang SI; Mun GH; Pyon JK; Jeon BJ; Lee JE
    Clin Breast Cancer; 2017 Jun; 17(3):204-210. PubMed ID: 28065399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omission of radiotherapy after breast conservation surgery in the postneoadjuvant setting.
    Esposito AC; Crawford J; Sigurdson ER; Handorf EA; Hayes SB; Boraas M; Bleicher RJ
    J Surg Res; 2018 Jan; 221():49-57. PubMed ID: 29229152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy in locally advanced breast cancer.
    Iqbal J; Shafi AA; Alharthi BN
    J Coll Physicians Surg Pak; 2014 Nov; 24(11):845-8. PubMed ID: 25404445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short term safety of oncoplastic breast conserving surgery for larger tumors.
    Wijgman DJ; Ten Wolde B; van Groesen NR; Keemers-Gels ME; van den Wildenberg FJ; Strobbe LJ
    Eur J Surg Oncol; 2017 Apr; 43(4):665-671. PubMed ID: 28041648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncoplastic Breast-Conserving Surgery Reduces Mastectomy and Postoperative Re-excision Rates.
    Crown A; Wechter DG; Grumley JW
    Ann Surg Oncol; 2015 Oct; 22(10):3363-8. PubMed ID: 26208579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast-conserving therapy after neoadjuvant chemotherapy: long-term results.
    Beriwal S; Schwartz GF; Komarnicky L; Garcia-Young JA
    Breast J; 2006; 12(2):159-64. PubMed ID: 16509842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rate of Breast-Conserving Surgery vs Mastectomy in Breast Cancer: a Tertiary Care Centre Experience from South India.
    Hassan Ali S; S P S; N AK
    Indian J Surg Oncol; 2019 Mar; 10(1):72-76. PubMed ID: 30948876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of breast conservation surgery in locally advanced breast cancer downstaged by neoadjuvant chemotherapy: a study in mastectomy specimens using simulation lumpectomy.
    Viswambharan JK; Kadambari D; Iyengar KR; Srinivasan K
    Indian J Cancer; 2005; 42(1):30-4. PubMed ID: 15805689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.
    Chen AM; Meric-Bernstam F; Hunt KK; Thames HD; Oswald MJ; Outlaw ED; Strom EA; McNeese MD; Kuerer HM; Ross MI; Singletary SE; Ames FC; Feig BW; Sahin AA; Perkins GH; Schechter NR; Hortobagyi GN; Buchholz TA
    J Clin Oncol; 2004 Jun; 22(12):2303-12. PubMed ID: 15197191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcome.
    Gentilini O; Intra M; Gandini S; Peruzzotti G; Winnikow E; Luini A; Veronesi P; Galimberti V; Goldhirsch A; Veronesi U
    J Surg Oncol; 2006 Oct; 94(5):375-9. PubMed ID: 16967462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitude.
    Debled M; MacGrogan G; Breton-Callu C; Ferron S; Hurtevent G; Fournier M; Bourdarias L; Bonnefoi H; Mauriac L; Tunon de Lara C
    Eur J Cancer; 2015 Apr; 51(6):697-704. PubMed ID: 25704790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome.
    Karanlik H; Ozgur I; Cabioglu N; Sen F; Erturk K; Kilic B; Onder S; Deniz M; Yavuz E; Aydiner A
    Eur J Surg Oncol; 2015 Sep; 41(9):1226-33. PubMed ID: 26141784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival.
    Vos EL; Siesling S; Baaijens MHA; Verhoef C; Jager A; Voogd AC; Koppert LB
    Breast Cancer Res Treat; 2017 Jul; 164(1):157-167. PubMed ID: 28389735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic response rates for breast cancer stages as a predictor of outcomes in patients receiving neoadjuvant chemotherapy followed by breast-conserving surgery.
    Zhang J; Lu CY; Chen HM; Wu SY
    Surg Oncol; 2021 Mar; 36():91-98. PubMed ID: 33316685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standard wide local excision or bilateral reduction mammoplasty in large-breasted women with small tumours: Surgical and patient-reported outcomes.
    Di Micco R; O'Connell RL; Barry PA; Roche N; MacNeill FA; Rusby JE
    Eur J Surg Oncol; 2017 Apr; 43(4):636-641. PubMed ID: 27908586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
    Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
    Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
    Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
    Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.